These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 27825025)

  • 1. Modification of polychlorinated phenols and evaluation of their toxicity, biodegradation and bioconcentration using three-dimensional quantitative structure-activity relationship models.
    Tong L; Guo L; Lv X; Li Y
    J Mol Graph Model; 2017 Jan; 71():1-12. PubMed ID: 27825025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of octanol-air partition coefficients for polychlorinated biphenyls (PCBs) using 3D-QSAR models.
    Chen Y; Cai X; Jiang L; Li Y
    Ecotoxicol Environ Saf; 2016 Feb; 124():202-212. PubMed ID: 26524653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentachlorophenol molecule design with lower bioconcentration through 3D-QSAR associated with molecule docking.
    Wang X; Chu Z; Yang J; Li Y
    Environ Sci Pollut Res Int; 2017 Nov; 24(32):25114-25125. PubMed ID: 28921381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D-QSAR studies on the toxicity of substituted benzenes to Tetrahymena pyriformis: CoMFA, CoMSIA and VolSurf approaches.
    Salahinejad M; Ghasemi JB
    Ecotoxicol Environ Saf; 2014 Jul; 105():128-34. PubMed ID: 24636479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular design of 1,3,5,7-TetraCN derivatives with reduced bioconcentration using 3D-QSAR modeling, full factorial design, and molecular docking.
    Zhao Y; Gu W; Li Y
    J Mol Graph Model; 2018 Sep; 84():197-214. PubMed ID: 30029045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-QSAR Studies on Barbituric Acid Derivatives as Urease Inhibitors and the Effect of Charges on the Quality of a Model.
    Ul-Haq Z; Ashraf S; Al-Majid AM; Barakat A
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27144563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach.
    Babu S; Sohn H; Madhavan T
    Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CoMFA and CoMSIA 3D-QSAR analysis on hydroxamic acid derivatives as urease inhibitors.
    Ul-Haq Z; Wadood A; Uddin R
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):272-8. PubMed ID: 18608766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-QSAR studies of substituted 1-(3, 3-diphenylpropyl)-piperidinyl amides and ureas as CCR5 receptor antagonists.
    Aher YD; Agrawal A; Bharatam PV; Garg P
    J Mol Model; 2007 Apr; 13(4):519-29. PubMed ID: 17345108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR studies of bioconcentration factors of polychlorinated biphenyls (PCBs) using DFT, PCS and CoMFA.
    Liu H; Liu H; Sun P; Wang Z
    Chemosphere; 2014 Nov; 114():101-5. PubMed ID: 25113189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
    Shagufta ; Kumar A; Panda G; Siddiqi MI
    J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of tricyclic oxazolidinones as antibacterial agents.
    Gopalakrishnan B; Khandelwal A; Rajjak SA; Selvakumar N; Das J; Trehan S; Iqbal J; Kumar MS
    Bioorg Med Chem; 2003 Jun; 11(12):2569-74. PubMed ID: 12757724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G; Saxena AK
    J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D QSAR studies of dioxins and dioxin-like compounds using CoMFA and CoMSIA.
    Ashek A; Lee C; Park H; Cho SJ
    Chemosphere; 2006 Oct; 65(3):521-9. PubMed ID: 16487571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
    Buolamwini JK; Assefa H
    J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2D and 3D-QSBR study on biodegradation of phenol derivatives.
    Wang F; Shi J
    Bull Environ Contam Toxicol; 2012 Aug; 89(2):316-21. PubMed ID: 22699709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists.
    Doddareddy MR; Cho YS; Koh HY; Pae AN
    Bioorg Med Chem; 2004 Aug; 12(15):3977-85. PubMed ID: 15246074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4.
    Gaurav A; Singh R
    Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacophore modeling, virtual screening and 3D-QSAR studies of 5-tetrahydroquinolinylidine aminoguanidine derivatives as sodium hydrogen exchanger inhibitors.
    Bhatt HG; Patel PK
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3758-65. PubMed ID: 22546667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.